Philips has reached an agreement with the shareholders of Shenzhen Goldway Industrial to acquire all outstanding shares in Goldway for an undisclosed fee.
Goldway will become part of the Patient Monitoring business within Philips’ Healthcare sector when the transaction closes in the second quarter of 2008
Goldway manufactures patient monitoring solutions that range from basic standalone to more fully-equipped monitors, including products that have been FDA approved in the US or carry CE certification in Europe.
The acquisition is expected to broaden Philips’ presence in the Chinese healthcare market, which is estimated to be growing at approximately 10 per cent per year.
‘Philips already has a leading position in the premium segment of
Invinity to build 20MWh flow battery in UK
Redux flow cells have had nowhere near the R+D effort compared to Lithium ion. They certainly have the potential (pun not intended) for longer...